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Purpose or Objective: In patients undergoing surgical 
resection of brain metastasis local recurrence is about 60%. 
Whole brain Radiation Therapy (WBRT) can significantly 
reduce the risk of local relapse but fails to improve overall 
survival. The most important side effects of WBRT are 
neurocognitive deficits, which can reduce quality of life. The 
goal of this study is to evaluate the role of stereotactic 
fractionated radiotherapy (SFRT) in patients with one to 
three brain metastases after surgical resection. 
 
Material and Methods: We performed a retrospective single-
institutional study in 60 patients undergoing SFRT of surgical 
cavity after resection of ≤3 brain metastases (November 2009 
- August 2013). The total irradiation dose was 30 Gy (5Gy/d, 
BED 45 Gy) after complete macroscopical resection and 35 Gy 
(5Gy/d, BED 52.5 Gy) in patients with macroscopic residual 
tumour after surgery. Macroscopic residual tumour was 
defined as contrast enhancement next to the resection cavity 
on the postoperative T1-MRI. We investigated local control 
(LC) as a primary endpoint. Intracranial distant intracranial 
tumour control (DC), overall survival (OS) and side effects 
were secondary endpoints. 
 
Results: The median follow-up for 52 patients was 8 months 
(1 to 32 months). 8 patients were lost to follow-up, due to 
mortality or morbidity. There were 6 (11.5%) local failures 
and 29 (55.8%) distant failures. Local control was correlated 
with age (p=0.046). Thirty-seven of 60 (61.7%) patients died 
during follow-up. Median overall survival was 15 months. Cox 
regression for survival was significant for KPS score ≤ 70% and 
size of PTV. No severe side effects were seen. Patients 
undergoing whole brain radiation therapy (WBRT) as salvage 
therapy in case of progression had no severe side effects. 
 
Conclusion: SFRT could be an alternative to WBRT after 
surgical resection of ≤3 brain metastasis. We had an 
encouraging rate of local control. Due to the high rate of 
distant intracranial failure regular follow-up with MRI is 
mandatory. No Grade 3, 4 or 5 adverse events were reported 
in patients undergoing WBRT or additional Stereotactic 
Radiotherapy as salvage therapy in case of intracranial 
progression. Prospective studies are warranted. 
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Purpose or Objective: Stereotactic body radiotherapy (SBRT) 
of vertebral metastases has emerged as a promising 
methodology, offering high rates of symptom relief and local 
control combined with low risk of toxicity. Nonetheless, local 
failure or spinal instability may occur, generating the need 
for subsequent surgery in the irradiated region. This study 
evaluated whether there is an increased incidence of intra- 
and post-surgical complications after high-dose radiotherapy. 
 
Material and Methods: Based on a retrospective international 
database of 704 cases of SBRT for vertebral metastases, 42 
patients treated at 7 different institutions were identified 
who underwent surgery in a previously stereotactic irradiated 
region. Data regarding surgical characteristics and 
complications were available for 38 patients. 
 
Results: Twenty women, 13 men, median age 59 years (range 
27 to 84 years) underwent SBRT for vertebral metastases 
followed by surgery. In 18 cases, conventional radiotherapy 
had been delivered prior to SBRT at a median dose of 30 Gy 
in median 10 fractions. SBRT was most frequently 
administered in 1 fraction with a mean prescription dose of 
20,9 Gy (mean EQD2/10 = 45,3Gy). The median time until the 
surgical intervention was performed was 7.5 months after 
SBRT. The most frequent reason for surgery was progressive 
pain (n=35) followed by progressive neurological 
deterioration (N=20) or fracture of the vertebral body (n=16). 
Therefore, open surgical decompression (n=29) and/or 
stabilization (n=22) were the most frequently performed 
surgical procedures. Increased fibrosis complicating the 
operation was explicitly stated in the surgical report in 5 
cases. In 3 patients a durotomy occurred which could be 
sufficiently sealed during the operation in two cases and 
required surgical revision in 1 case. Median blood loss was 
425 ml, but 5 patients had a blood loss of >1l during the 
procedure. After the operation, 2 patients suffered from an 
increased neurological deficit which could be explained by an 
epidural hematoma in one case. Delayed wound healing was 
reported in 4 cases. In one patient this lasted for 5 months 
after surgery until death. One patient died shortly after the 
surgical procedure due to unknown causes. 
 
Conclusion: In this largest series of surgical interventions 
following spine SBRT, the overall complication rate was 45%. 
This appears to be higher when compared to primary surgery 
without previous SBRT. Therefore, spine surgery after SBRT is 
technically feasible. However, the decision to perform 
surgical procedures in these highly complex cases should be 
made by a multidisciplinary team and their performance in 
an experienced center may be beneficial. 
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Purpose or Objective: Hypofractionated Stereotactic 
radiosurgery (HSRS) delivered in few fractions, up to 5, has 
been employed in patients with large brain metastases (BM), 
alone or after surgical resection on tumor bed, as an 
alternative to whole brain radiotherapy or to single fraction 
SRS with the aim to reduce late radiation-induced toxicity 
while maintaining high local control rate. The aim of this 
study was to evaluate the outcome and toxicity of patients 
treated for large brain metastases using HSRS, in terms of 
local control, incidence of distant brain metastases (DBM) 
and toxicity  
 
